{"doi":"10.1097/qad.0000000000000106","title":"Prevalence of broadly neutralizing antibody responses during chronic HIV-1 infection","abstract":null,"journal":"AIDS","year":2014,"id":21647,"datarank":8.037131194050515,"base_score":5.902633333401366,"endowment":5.902633333401366,"self_citation_contribution":0.885395000010205,"citation_network_contribution":7.151736194040311,"self_endowment_contribution":0.885395000010205,"citer_contribution":7.151736194040311,"corpus_percentile":null,"corpus_rank":null,"citation_count":365,"citer_count":200,"citers_with_citation_signal":200,"citers_with_endowment":200,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":16991,"name":"Michael S. Seaman","orcid":"0000-0001-6444-3562","position":1,"is_corresponding":false},{"id":138594,"name":"Robert T. Bailer","orcid":null,"position":2,"is_corresponding":false},{"id":105614,"name":"John R. Mascola","orcid":"0000-0002-5293-4695","position":3,"is_corresponding":false},{"id":103755,"name":"David C. Montefiori","orcid":"0000-0003-0856-6319","position":4,"is_corresponding":false},{"id":138597,"name":"Bette T. Korber","orcid":null,"position":5,"is_corresponding":false},{"id":138592,"name":"Peter Hraber","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":5.902633333401366,"endowment":5.902633333401366,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"24361678","pmcid":"PMC4042313","openalex_id":"https://openalex.org/W2093961711","authors":[],"funders":[{"funder_name":"NIAID NIH HHS","grant_id":"UM1 AI100645","title":null},{"funder_name":"Intramural NIH HHS","grant_id":"","title":null},{"funder_name":"Intramural NIH HHS","grant_id":"","title":null}],"total_grants":3,"fwci":12.6103,"citation_percentile":0.99123399,"influential_citations":12,"citation_trend":[{"year":2013,"count":1},{"year":2014,"count":26},{"year":2015,"count":29},{"year":2016,"count":38},{"year":2017,"count":45},{"year":2018,"count":32},{"year":2019,"count":29},{"year":2020,"count":27},{"year":2021,"count":37},{"year":2022,"count":25},{"year":2023,"count":31},{"year":2024,"count":18},{"year":2025,"count":22},{"year":2026,"count":5}],"oa_status":"closed","license":null,"oa_locations":[{"url":"https://journals.lww.com/aidsonline/Fulltext/2014/01140/Prevalence_of_broadly_neutralizing_antibody.2.aspx","host_type":"HYBRID"},{"url":"https://journals.lww.com/10.1097/QAD.0000000000000106","host_type":"publisher"},{"url":"https://doi.org/10.1097/qad.0000000000000106","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/24361678","host_type":"repository"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4042313","host_type":"repository"}],"fields_of_study":["HIV Research and Treatment","Biological Research and Disease Studies","HIV/AIDS drug development and treatment","Medicine","Antibodies, Neutralizing","HIV Antibodies","HIV Infections","HIV-1","Humans","Neutralization Tests"],"mesh_terms":["Humans","Neutralization Tests","HIV Antibodies","HIV-1","HIV Infections","Antibodies, Neutralizing"],"keywords":["Neutralization","Neutralizing antibody","Virology","Potency","Antibody","Immunology","Biology","Medicine","In vitro","Genetics"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-06-06T16:27:14.015659Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}